NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia

American Journal of Pathology

Volumn 151, Issue 6, 1997, Pages 1685-1694

  Sirica, Alphonse E ^a   Radaeva, Svetlana ^a   Caran, Nicole ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT CARCINOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RNA TRANSCRIPTION;

ADENOMA, BILE DUCT; ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BLOTTING, WESTERN; CHOLESTASIS; DISEASE MODELS, ANIMAL; FURANS; GENE EXPRESSION REGULATION, NEOPLASTIC; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; LIVER; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344; RECEPTOR, ERBB-2;

EID: 0030689866     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Voravud N, Foster CS, Gilbertson JA, Sikora K, Waxman J: Oncogene expression in cholangiocarcinoma and in normal hepatic development. Hum Pathol 1989, 20:1163-1168
2. Motojima K, Komuta K, Hiasa A, Tsuribune T, Hashimoto T, Tsunoda T, Kanematsu T: Evaluation of immunoreactivity to erbB-2 protein as a marker of prognosis in bile duct carcinoma. Nippon Geka Gakkai Zasshi 1992, 93:952-955
3. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182
4. Borg A, Tandon AK, Sigurdsson H, Clark GM, Fernö M, Fuqua SAW, Killander D, McGuire WL: HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res 1990, 50:4332-4337
5. Collier JD, Guo K, Mathew J, May FEB, Bennett MK, Corbett IP, Bassendine MF, Burt AD: c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma. J Hepatol 1992, 14:377-380
6. Carver RS, Sliwkowski MX, Sitaric S, Russell WE: Insulin regulates heregulin binding and erbB3 expression in rat hepatocytes. J Biol Chem 1996, 271:13491-13496
7. Polimeno L, Azzarone A, Zeng GH, Panella C, Subbotin V, Carr B, Bouzahzah B, Francavilla A, Starzl TE: Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells. Hepatology 1995, 21:1070-1078
8. Maronpot RR, Giles HD, Dykes DJ, Irwin RD: Furan-induced hepatic cholangiocarcinomas in Fischer 344 rats. Toxicol Pathol 1991, 19: 561-570
9. Elmore LW, Sirica AE: Phenotypic characterization of metaplastic intestinal glands and ductular hepatocytes in cholangiofibrotic lesions rapidly induced in the caudate liver lobe of rats treated with furan. Cancer Res 1991, 51:5752-5759
10. Elmore LW, Sirica AE: Sequential appearance of intestinal mucosal cell types in the right and caudate liver lobes of furan-treated rats. Hepatology 1992, 16:1220-1226
11. Elmore LW, Sirica AE: "Intestinal-type" of adenocarcinoma preferentially induced in right/caudate liver lobes of rats treated with furan. Cancer Res 1993, 53:254-259
12. Sirica AE: Biliary proliferation and adaptation in furan-induced rat liver injury and carcinogenesis. Toxicol Pathol 1996, 24:90-99
13. Sirica AE, Gainey TW, Harrell MB, Caran N: Cholangiocarcinogenesis and biliary adaptation responses in hepatic injury. Biliary and Pancreatic Ductal Epithelia: Pathobiology and Pathophysiology. Edited by Sirica AE, Longnecker DS New York, Marcel Dekker, 1997, pp 229-290
14. Sirica AE: Biology of biliary epithelial cells. Prog Liver Dis 1992, X:63-87
15. Kozuka S, Kurashina M, Tsubone M, Hachisuka K, Yasui A: Significance of intestinal metaplasia for the evolution of cancer in the biliary tract. Cancer 1984, 54:2277-2285
16. Sirica AE, Cole SL, Williams T: A unique rat model of bile ductular hyperplasia in which liver is almost totally replaced with well-differentiated bile ductules. Am J Pathol 1994, 144:1257-1268
17. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76:4350-4354
18. Hsu S-M, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981, 29:577-580
19. Falck VG, Gullick WJ: c-erbB-2 oncogene product staining in gastric adenocarcinoma: an immunohistochemical study. J Pathol 1989, 159: 107-111
20. Hilton DA, West KP: c-erbB-2 oncogene product expression and prognosis in gastric carcinoma. J Clin Pathol 1992, 45:454-456
21. Wu M-S, Shun C-T, Wang H-P, Sheu J-C, Lee W-J, Wang T-H, Lin J-T: Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology 1997, 112:1457-1465
22. Fernández JL, Goyanes V, López-Fernández C, Buño I, Gosálvez J: Quantification of c-erbB-2 gene amplification in breast cancer cells using fluorescence in situ hybridization and digital image analysis. Cancer Genet Cytogenet 1996, 86:18-21
23. Hall PA, Hughes CM, Staddon SL, Richman Pl, Gullick WJ, Lemoine NR: The c-erbB-2 proto-oncogene in human pancreatic cancer. J Pathol 1990, 161:195-200
24. Yamanaka Y, Friess H, Kobrin MS, Büchler M, Kunz J, Beger HG, Korc M: Overexpression of HER-2/neu oncogene in human pancreatic carcinoma. Hum Pathol 1993, 24:1127-1134
25. Mortelmans K, Haworth S, Lawlor T, Speck W, Tainer B, Zeiger E: Salmonella mutagenicity tests. II. Results from the testing of 270 chemicals. Environ Mutagen 1986, 8(Suppl 7):1-119
26. Wilson DM, Goldsworthy TL, Popp JA, Butterworth BE: Evaluation of genotoxicity, pathological lesions, and cell proliferation in livers of rats and mice treated with furan. Environ Mol Mutagen 1992, 19:209-222
27. Mathis GA, Sirica AE: Effects of medium and substratum conditions on the rates of DNA synthesis in primary cultures of bile ductular epithelial cells. In Vitro Cell Dev Biol 1990, 26:113-118
28. Sirica AE, Gainey TW: A new rat bile ductular epithelial cell culture model characterized by the appearance of polarized bile ducts in vitro. Hepatology 1997, 26:537-549
29. Matsumoto K, Fujii H, Michalopoulos G, Fung JJ, Demetris AJ: Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology 1994, 20:376-382
30. Shimizu Y, Demetris AJ, Gollin SM, Storto PD, Bedford HM, Altarac S, Iwatsuki S, Herberman RB, Whiteside TL: Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells. Int J Cancer 1992, 52:252-260
31. Ishii M, Vroman BT, LaRusso NF: Morphological demonstration of receptor-mediated endocytosis of epidermal growth factor by isolated bile duct epithelial cells. Gastroenterology 1990, 98:1284-1291
32. Riese DJ II, Kim ED, Elenius K, Buckley S, Klagsbrun M, Plowman GD, Stern DF. The epidermal growth factor receptor couples transforming growth factor-, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. J Biol Chem 1996, 271:20047-20052
33. Worthylake R, Wiley HS: Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu. J Biol Chem 1997, 272:8594-8601
34. Nonomura A, Ohta G, Nakanuma Y, Izumi R, Mizukami Y, Matsubara F, Hayashi M, Watanabe K, Takayanagi N: Simultaneous detection of epidermal growth factor receptor (EGF-R), epidermal growth factor (EGF) and ras p21 in cholangiocarcinoma by an immunocytochemical method. Liver 1988, 8:157-166
35. King CR, Borrello I, Bellot F, Comoglio P, Schlessinger J: EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-8R-3. EMBO J 1988, 7:1647-1651
36. Terada T, Nakanuma Y, Sirica AE: Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis. Hum Pathol 1998 (in press)
37. Sirica AE, Terada T, Harrell MB, Caran N, Gainey TW: Rat "intestinal-type" cholangiocarcinomas closely resemble human well differentiated tubular cholangiocarcinomas in their overexpression of both Met and ErbB-2 and exhibit growth factor immunoreactivities that appear to reflect differentiation along the intestinal rather than biliary lineage. Hepatology 1996, 24:471A
38. Presnell SC, Stolz DB, Mars WM, Jo M, Michalopoulos GK, Strom SC: Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-α in rat liver epithelial cells. Mol Carcinogen 1997, 18:244-255
39. Chen G, Seol D-W, Carr B, Zarnegar R: Co-expression and regulation of Met and Ron proto-oncogenes in human hepatocellular carcinoma tissues and cell lines. Hepatology 1997, 26:59-66